-
1
-
-
84988421413
-
Chronic expression of interferon-gamma leads to murine autoimmune cholangitis with a female predominance
-
Bae HR, Leung PS, Tsuneyama K, et al. Chronic expression of interferon-gamma leads to murine autoimmune cholangitis with a female predominance. Hepatology. 2016;64:1189–1201.
-
(2016)
Hepatology
, vol.64
, pp. 1189-1201
-
-
Bae, H.R.1
Leung, P.S.2
Tsuneyama, K.3
-
2
-
-
84959064216
-
Chemokine and chemokine receptors in autoimmunity: the case of primary biliary cholangitis
-
Choi J, Selmi C, Leung PS, et al. Chemokine and chemokine receptors in autoimmunity: the case of primary biliary cholangitis. Expert Rev Clin Immunol. 2016;12:661–672.
-
(2016)
Expert Rev Clin Immunol
, vol.12
, pp. 661-672
-
-
Choi, J.1
Selmi, C.2
Leung, P.S.3
-
3
-
-
84976519930
-
Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: a proof-of-concept study
-
Hirschfield GM, Gershwin ME, Strauss R, et al. Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: a proof-of-concept study. Hepatology. 2016;64:189–199.
-
(2016)
Hepatology
, vol.64
, pp. 189-199
-
-
Hirschfield, G.M.1
Gershwin, M.E.2
Strauss, R.3
-
4
-
-
84953306524
-
AAV-IL-22 modifies liver chemokine activity and ameliorates portal inflammation in murine autoimmune cholangitis
-
Hsueh YH, Chang YN, Loh CE, Gershwin ME, Chuang YH. AAV-IL-22 modifies liver chemokine activity and ameliorates portal inflammation in murine autoimmune cholangitis. J Autoimmun. 2016;66:89–97.
-
(2016)
J Autoimmun
, vol.66
, pp. 89-97
-
-
Hsueh, Y.H.1
Chang, Y.N.2
Loh, C.E.3
Gershwin, M.E.4
Chuang, Y.H.5
-
5
-
-
84953345460
-
Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways
-
Hudspeth K, Donadon M, Cimino M, et al. Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways. J Autoimmun. 2016;66:40–50.
-
(2016)
J Autoimmun
, vol.66
, pp. 40-50
-
-
Hudspeth, K.1
Donadon, M.2
Cimino, M.3
-
6
-
-
84962106535
-
A contemporary perspective on the molecular characteristics of mitochondrial autoantigens and diagnosis in primary biliary cholangitis
-
Leung PS, Choi J, Yang G, et al. A contemporary perspective on the molecular characteristics of mitochondrial autoantigens and diagnosis in primary biliary cholangitis. Expert Rev Mol Diagn. 2016;16:697–705.
-
(2016)
Expert Rev Mol Diagn
, vol.16
, pp. 697-705
-
-
Leung, P.S.1
Choi, J.2
Yang, G.3
-
7
-
-
84957434981
-
Differential phenotypic and functional properties of liver-resident NK cells and mucosal ILC1s
-
Tang L, Peng H, Zhou J, et al. Differential phenotypic and functional properties of liver-resident NK cells and mucosal ILC1s. J Autoimmun. 2016;67:29–35.
-
(2016)
J Autoimmun
, vol.67
, pp. 29-35
-
-
Tang, L.1
Peng, H.2
Zhou, J.3
-
8
-
-
84928587439
-
Systems biologic analysis of T regulatory cells genetic pathways in murine primary biliary cirrhosis
-
Wang YH, Yang W, Yang JB, et al. Systems biologic analysis of T regulatory cells genetic pathways in murine primary biliary cirrhosis. J Autoimmun. 2015;59:26–37.
-
(2015)
J Autoimmun
, vol.59
, pp. 26-37
-
-
Wang, Y.H.1
Yang, W.2
Yang, J.B.3
-
9
-
-
84946472960
-
The immunogenetics of primary biliary cirrhosis: a comprehensive review
-
Webb GJ, Siminovitch KA, Hirschfield GM. The immunogenetics of primary biliary cirrhosis: a comprehensive review. J Autoimmun. 2015;64:42–52.
-
(2015)
J Autoimmun
, vol.64
, pp. 42-52
-
-
Webb, G.J.1
Siminovitch, K.A.2
Hirschfield, G.M.3
-
10
-
-
85016475353
-
Old and new treatments for primary biliary cholangitis
-
Chascsa D, Carey E, Lindor K. Old and new treatments for primary biliary cholangitis. Liver Int 2017;37:490–499.
-
(2017)
Liver Int
, vol.37
, pp. 490-499
-
-
Chascsa, D.1
Carey, E.2
Lindor, K.3
-
11
-
-
84982102773
-
A placebo-controlled trial of obeticholic acid in primary biliary cholangitis
-
Nevens F, Andreone P, Mazzella G, et al. A placebo-controlled trial of obeticholic acid in primary biliary cholangitis. N Engl J Med. 2016;375:631–643.
-
(2016)
N Engl J Med
, vol.375
, pp. 631-643
-
-
Nevens, F.1
Andreone, P.2
Mazzella, G.3
-
12
-
-
84949105616
-
The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis
-
Carbone M, Sharp SJ, Flack S, et al. The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis. Hepatology. 2016;63:930–950.
-
(2016)
Hepatology
, vol.63
, pp. 930-950
-
-
Carbone, M.1
Sharp, S.J.2
Flack, S.3
-
13
-
-
84952986849
-
Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy
-
e4
-
Lammers WJ, Hirschfield GM, Corpechot C, et al. Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy. Gastroenterology. 2015;149:1804–1812. e4.
-
(2015)
Gastroenterology
, vol.149
, pp. 1804-1812
-
-
Lammers, W.J.1
Hirschfield, G.M.2
Corpechot, C.3
-
15
-
-
84891921511
-
Guidelines for the management of primary biliary cirrhosis: the Intractable Hepatobiliary Disease Study Group supported by the Ministry of Health, Labour and Welfare of Japan
-
Working Subgroup for Clinical Practice Guidelines for Primary Biliary C. Guidelines for the management of primary biliary cirrhosis: the Intractable Hepatobiliary Disease Study Group supported by the Ministry of Health, Labour and Welfare of Japan. Hepatol Res 2014;44(Suppl S1):71–90.
-
(2014)
Hepatol Res
, vol.44
, pp. 71-90
-
-
-
16
-
-
84982170263
-
Primary biliary cholangitis–A new name and a new treatment
-
Pratt DS. Primary biliary cholangitis–A new name and a new treatment. N Engl J Med. 2016;375:685–687.
-
(2016)
N Engl J Med
, vol.375
, pp. 685-687
-
-
Pratt, D.S.1
-
17
-
-
84992602694
-
From old concerns to new advances and personalized medicine in lupus: the end of the tunnel is approaching
-
Doria A, Gershwin ME, Selmi C. From old concerns to new advances and personalized medicine in lupus: the end of the tunnel is approaching. J Autoimmun. 2016;74:1–5.
-
(2016)
J Autoimmun
, vol.74
, pp. 1-5
-
-
Doria, A.1
Gershwin, M.E.2
Selmi, C.3
|